Factors Associated with Poor Glycemic and Lipid Levels in Ambulatory Diabetes Mellitus Type 2 Patients in Asmara, Eritrea: A Cross-Sectional Study
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Objective. There is a dearth of relevant research on the rapidly evolving epidemic of diabetes mellitus (particularly Type 2 diabetes mellitus) in sub-Saharan Africa. To address some of these issues in the Eritrean context, we conducted a cross-sectional study on glycemic and lipid profiles and associated risk factors. Methods. A total of 309 patients with diabetes mellitus on regular follow-up at the Diabetic and Hypertensive Department at Halibet Regional Referral Hospital, Asmara, were enrolled for the study. Data on specific clinical chemistry and anthropomorphic parameters was collected. Chi-squared (χ2) test or Fischer’s exact test was used to evaluate the relationship between specific variables. Multivariate logistic regression (backward: conditional) was undertaken to identify the factors associated with increased odds of suboptimal values in glucose and specific lipid panel subfractions. Results. High proportions of patients (76.7%) had suboptimal levels of HbA1c with a mean±SD of 8.6%±1.36, respectively. In multivariate regression analysis, the likelihood of HbA1c≥7% was higher in patients with abnormal WHR (AOR=3.01, 95% CI, 3.01 (1.15–7.92=0.024)) and in patients without hypertension (AOR=1.97, 95% CI (1.06–3.56), p=0.021). A unit reduction in eGFR was also associated with HbA1c≥7% (AOR=0.99, 95% CI (0.98–1=0.031)). In a separate analysis, the data shows that 80.9% of the patients had dyslipidemia. In particular, 62.1% of the patients had TC≥200 mg/dL (risk factors: sex, hypertension, and HbA1c concentration), 81.6% had LDL‐C≥100 mg/dL (risk factors: sex and hypertension), 56.3% had TG≥150 (risk factors: sex, HbA1c, and waist circumference), 62.8% had abnormal HDL-C (risk factors: waist circumference), 78.3% had non‐HDL<130 mg/dL (risk factors: duration of disease, reduced estimated glomerular filtration rate, and HbA1c), and 45.3% had abnormal TG/HDL (risk factors: sex, age of patient, FPG, and waist circumference). Conclusions. The quality of care, as measured by glycemic and specific lipid targets, in this setting is suboptimal. Therefore, there is an urgent need for simultaneous improvements in both indicators. This will require evidence-based optimization of pharmacological and lifestyle interventions. Therefore, additional studies, preferably longitudinal studies with long follow-up, are required on multiple aspects of DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The prevalence ranged between 45.2% and 93% [22,27].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This systematic review included 12 articles that met the eligible criteria (Table 1) [16-27].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The included articles were published either in 2021 [16-22] or in 2020 [23-27]. No articles were published in 2022.”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The design of studies was commonly cross-sectional. There were 10 cross-sectional studies [16,18-25,27], whereas the remaining two studies were either retrospective observational [17] or retrospective [26].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“The included 12 articles were from nine different countries: two studies from Ethiopia [16,22], two studies from Saudi Arabia [18,26], one study from Iraq [17], two studies from Indonesia [19,25], one study from Brazil [20], one study from Burkina Faso [21], one study from Morocco [23], one study from Eretria [24], and one study from Egypt [27].”
From Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review (2022) · cites this paper as [22]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International physical activity questionnaire: 12-country reliability and validity
CRAIG, C. L., MARSHALL, A. L., SJ??STR??M, M., BAUMAN, A. E., BOOTH, M. L., AINSWORTH, B. E., PRATT, M., EKELUND, U., YNGVE, A., SALLIS, J. F., et al. (2003) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000078924.61453.fb · Cited by 21,619 · cited 1×
“Not to be forgotten is the fact that several studies have demonstrated that the efficacy and adherence rates to multimodal behaviour interventions are notoriously poor [36].”
BackgroundSaeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., et al. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107843 · Cited by 10,792
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837 · cited 2×
“Diabetes mellitus (DM) describes a constellation of metabolic disorders characterised by hyperglycemia and disturbances to carbohydrate, fat, and protein metabolism resulting from insulin deficiency, insulin resistance, or both [1].”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014 · cited 1×
“The comparatively high prevalence of abnormal TC and LDL-C in females has been reported in landmark studies such as the UK Prospective Diabetes Study (UKPDS) [40].”
BackgroundJellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094 · cited 2×
“According to the fitted logistic regression model, abnormal non-LDL-C was associated with adverse risk factors such as longer duration of DM, abnormal HbA1c, presence of hypertension, and reduced eGFR in line with previous studies [41].”
BackgroundResultBlood Pressure Lowering in Type 2 Diabetes: A Systematic Review and Meta-analysis
Emdin, C. A., Rahimi, K., Neal, B., Callender, T., Perkovic, V., & Patel, A. (2015) · JAMA · doi:10.1001/jama.2014.18574 · Cited by 854
Diabetes and hypertension: a position statement by the American Diabetes Association
de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S., & Bakris, G. (2017) · Diabetes Care · doi:10.2337/dci17-0026 · Cited by 714
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetologia · doi:10.1007/s00125-008-1157-y · Cited by 712 · cited 1×
“Despite the growing burden of DM [9] and the existence of a fairly robust clinical armamentarium (pharmacological and nonpharmacological) for optimal management of the disease [10], several studies have demonstrated that the quality of care for patients, particularly in SSA, is generally wanting [11–13].”
BackgroundPathophysiology of diabetic dyslipidaemia: where are we?
Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708
Lorenzo, C., Williams, K., Hunt, K. J., & Haffner, S. M. (2007) · Diabetes Care · doi:10.2337/dc06-1414 · Cited by 662
Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality
Cui, Y., Blumenthal, R. S., Flaws, J. A., Whiteman, M. K., Langenberg, P., Bachorik, P. S., & Bush, T. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.11.1413 · Cited by 658
McLaughlin, T., Reaven, G., Abbasi, F., Lamendola, C., Saad, M., Waters, D., Simon, J., & Krauss, R. M. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.03.085 · Cited by 658 · cited 2×
“The connection between TG/HDL, FPG, and WC uncovered in this study is interesting given the fact that abnormal WC has previously been proposed as a marker of insulin resistance [45].”
BackgroundGoodpaster, B. H., Krishnaswami, S., Resnick, H., Kelley, D. E., Haggerty, C., Harris, T. B., Schwartz, A. V., Kritchevsky, S., & Newman, A. B. (2003) · Diabetes Care · doi:10.2337/diacare.26.2.372 · Cited by 619 · cited 1×
“To explain this phenomenon, it has been suggested that agerelated increases in total body fat and visceral adiposity compromise the reliability of BMI as a sensitive marker of adiposity in older age groups [29].”
BackgroundGæde, P., Oellgaard, J., Carstensen, B., Rossing, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2016) · Diabetologia · doi:10.1007/s00125-016-4065-6 · Cited by 528
Interaction between Glucose and Lipid Metabolism: More than Diabetic Dyslipidemia
Parhofer, K. G. (2015) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2015.39.5.353 · Cited by 458 · cited 1×
“Multiple pathophysiological processes underlying these complications have been proposed [6].”
BackgroundThe 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes Prevention
The Diabetes Prevention Program Research Group (2012) · Diabetes Care · doi:10.2337/dc11-1468 · Cited by 436
Standards of Medical Care in Diabetes—2018 Abridged for Primary Care Providers
American Diabetes Association (2018) · Clinical Diabetes · doi:10.2337/cd17-0119 · Cited by 348 · cited 4×
“American Diabetic Association (ADA) guidelines were used to categorize FPG and HbA1c [8].”
BackgroundMethodInfluentialDiabetes in the Africa region: An update
Peer, N., Kengne, A.-P., Motala, A. A., & Mbanya, J. C. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.006 · Cited by 222
Zheng, S., Shi, S., Ren, X., Han, T., Li, Y., Chen, Y., Liu, W., Hou, P. C., & Hu, Y. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1020-8 · Cited by 203 · cited 1×
“Needless to say, the link between glycemic control and WHR (marker of abdominal obesity, hence insulin resistance) and high FPG is in line with reports from other studies [27].”
ResultDiabetes in Sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia
Azevedo, M., & Alla, S. (2008) · International Journal of Diabetes in Developing Countries · doi:10.4103/0973-3930.45268 · Cited by 168
Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors
Danquah, I., Bedu-Addo, G., Terpe, K.-J., Micah, F., Amoako, Y. A., Awuku, Y. A., Dietz, E., van der Giet, M., Spranger, J., & Mockenhaupt, F. P. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-210 · Cited by 163 · cited 1×
“Multiple studies and reports have concluded that the disproportionate number of DM patients with poor glycemic control is traceable to both institutional and individual factors including drug cost and availability, health policy disparities, limited self-monitoring of blood glucose (SMBG), widespread use of herbal the…”
BackgroundEconomic burden of diabetes mellitus in the WHO African region
Kirigia, J. M., Sambo, H. B., Sambo, L. G., & Barry, S. P. (2009) · BMC International Health and Human Rights · doi:10.1186/1472-698x-9-6 · Cited by 159
Dyslipidemia, Kidney Disease, and Cardiovascular Disease in Diabetic Patients
Chen, S.-C., & Tseng, C.-H. (2013) · The Review of Diabetic Studies · doi:10.1900/rds.2013.10.88 · Cited by 152
Coronary microvascular dysfunction in diabetes mellitus
Kibel, A., Selthofer-Relatic, K., Drenjancevic, I., Bacun, T., Bosnjak, I., Kibel, D., & Gros, M. (2017) · Journal of International Medical Research · doi:10.1177/0300060516675504 · Cited by 139 · cited 2×
“Other hitherto underappreciated complications include infections, mental illness, cognitive decline, lung diseases, and some cancers [5].”
BackgroundKassahun, T., Eshetie, T., & Gesesew, H. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1896-7 · Cited by 135 · cited 1×
“In particular, substantial variability within and between countries in the magnitude of poor glycemic control has also been reported [12, 13].”
BackgroundPATJA, K., JOUSILAHTI, P., HU, G., VALLE, T., QIAO, Q., & TUOMILEHTO, J. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01545.x · Cited by 102
Tekalegn, Y., Addissie, A., Kebede, T., & Ayele, W. (2018) · PLOS ONE · doi:10.1371/journal.pone.0193442 · Cited by 101
The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus
Toth, P. P., Simko, R. J., Palli, S. R., Koselleck, D., Quimbo, R. A., & Cziraky, M. J. (2012) · Cardiovascular Diabetology · doi:10.1186/1475-2840-11-109 · Cited by 98 · cited 1×
“The characteristic alterations consist of low HDL-C and high TG [38].”
BackgroundAngamo, M. T., Melese, B. H., & Ayen, W. Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061759 · Cited by 68 · cited 2×
“Smokers were categorized as (a) nonsmokers (individuals who had not smoked or previous smokers who had quit for more than one year prior to the study commencement) and (b) smokers (current user of at least one cigarette a day or occasional smokers) [17].”
BackgroundMethodTohidi, M., Hatami, M., Hadaegh, F., Safarkhani, M., Harati, H., & Azizi, F. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-6 · Cited by 61 · cited 3×
“At the present time, evidence in the literature suggests that reliance on isolated lipid parameters may miss prognostically relevant lipid abnormalities [44, 45].”
BackgroundKibirige, D., Atuhe, D., Sebunya, R. K., & Mwebaze, R. M. (2014) · Journal of Diabetes & Metabolic Disorders · doi:10.1186/2251-6581-13-40 · Cited by 59 · cited 1×
“Prominent factors include ethnicity, high levels of poverty, limited in-country funding for DM clinics, cultural obstacles, underdiagnosis, poor laboratory infrastructure, uncoordinated care, and shortage of physicians or other medical health specialists [14].”
BackgroundMeasures of general and central obesity and risk of type 2 diabetes in a Ghanaian population
Frank, L. K., Heraclides, A., Danquah, I., Bedu‐Addo, G., Mockenhaupt, F. P., & Schulze, M. B. (2012) · Tropical Medicine & International Health · doi:10.1111/tmi.12024 · Cited by 58 · cited 11×
“Despite the growing burden of DM [9] and the existence of a fairly robust clinical armamentarium (pharmacological and nonpharmacological) for optimal management of the disease [10], several studies have demonstrated that the quality of care for patients, particularly in SSA, is generally wanting [11–13].”
ResultInfluentialAssessment of glycemic control in type 2 diabetes in the Eastern Sudan
Omar, S. M., Musa, I. R., Osman, O. E., & Adam, I. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3480-9 · Cited by 53
Cheneke, W., Suleman, S., Yemane, T., & Abebe, G. (2016) · BMC Research Notes · doi:10.1186/s13104-016-1921-x · Cited by 50 · cited 1×
“In particular, substantial variability within and between countries in the magnitude of poor glycemic control has also been reported [12, 13].”
BackgroundDaya, R., Bayat, Z., & Raal, F. J. (2017) · Journal of Endocrinology Metabolism and Diabetes of South Africa · doi:10.1080/16089677.2017.1360064 · Cited by 44 · cited 12×
“Despite the growing burden of DM [9] and the existence of a fairly robust clinical armamentarium (pharmacological and nonpharmacological) for optimal management of the disease [10], several studies have demonstrated that the quality of care for patients, particularly in SSA, is generally wanting [11–13].”
BackgroundResultInfluentialfor the Diabetes Prevention Program Research Group, Hoskin, M. A., Bray, G. A., Hattaway, K., Khare-Ranade, P. A., Pomeroy, J., Semler, L. N., Weinzierl, V. A., & Wylie-Rosett, J. (2014) · Current Nutrition Reports · doi:10.1007/s13668-014-0094-2 · Cited by 40
Zheng, Y., Sun, Q., Chen, K., Yan, W., Pan, C., Lu, J., Dou, J., Lü, Z., Ba, J., Wang, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109765 · Cited by 24
Impact of a Multidisciplinary Intervention for Diabetes in Eritrea
Windus, D. W., Ladenson, J. H., Merrins, C. K., Seyoum, M., Windus, D., Morin, S., Tewelde, B., Parvin, C. A., Scott, M. G., & Goldfeder, J. S. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.095067 · Cited by 23 · cited 1×
“Emphasising some of these factors, a previous research team in the same facility asserted that sustainable upgraded laboratory services combined with training in clinical management may be the key to the attainment of sustainable improvements in DM care in LMIC such as Eritrea [26].”
BackgroundOtieno, F. C. F., Kanu, J. E., Karari, E. M., Okech, V., Joshi, M. D., & Mutai, K. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s124473 · Cited by 23
Profile of patients with diabetes in Eritrea: results of first phase registry analyses
Seyum, B., Mebrahtu, G., Usman, A., Mufunda, J., Tewolde, B., Haile, S., Kosia, A., & Negassi, E. (2009) · Acta Diabetologica · doi:10.1007/s00592-009-0093-8 · Cited by 19 · cited 1×
“Existing literature is dated or limited in scope [16].”
BackgroundOvbiagele, B. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.11.023 · Cited by 13 · cited 1×
“Emphasising these facts, some scholars have stressed the fact that very few countries in the continent can afford to broadly screen and treat the various complications associated with DM [3].”
BackgroundEvaluation of factors related to glycaemic control among South Korean patients with type 2 diabetes
Choi, W., Seo, Y., & Ha, Y. (2017) · International Journal of Nursing Practice · doi:10.1111/ijn.12616 · Cited by 5
Research works printed but not linked: 1
- 2016, International Journal of Medicine and Health Profession Research, 3, 82
Cited by
Saher, T., Al-Worafi, Y. M., Iqbal, M. N., Wahid, A., Iqbal, Q., Khan, A., Atif, M., & Ahmad, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.978345 · Cited by 370
Glycemic Control for Type 2 Diabetes Mellitus Patients: A Systematic Review
Bin Rakhis, S. A., AlDuwayhis, N. M., Aleid, N., AlBarrak, A. N., & Aloraini, A. A. (2022) · Cureus · doi:10.7759/cureus.26180 · Cited by 152
Ekpor, E., Akyirem, S., & Duodu, P. A. (2023) · Annals of Medicine · doi:10.1080/07853890.2023.2182909 · Cited by 72
Lubaki, J.-P. F., Omole, O. B., & Francis, J. M. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00902-0 · Cited by 87
Hosseini, S. A., Hamzavi, K., Safarzadeh, H., & Salehi, O. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1826529 · Cited by 15
“Diabetes mellitus (DM) is a metabolic disorder that results from an increase in blood glucose as a result of impaired metabolism of carbohydrates, lipids, and proteins, leading to decreased insulin secretion, increased insulin resistance, or both (Achila et al. 2020).”
Background
Metadata
- Authors
- Achila, O. O., Ghebretinsae, M., Kidane, A., Simon, M., Makonen, S., & Rezene, Y.
- Affiliations
- Department of Clinical Laboratory Sciences, Orotta College of Medicine and Health Sciences, Eritrea
- University of Asmara (ER)
- Corresponding author
- Achila, Oliver Okoth
- Venue
- Journal of Diabetes Research
- Publisher
- Wiley
- Published
- 2020-01-29
- Volume
- 2020
- Pages
- 1-12
- ISSN
- 2314-6745 (ISSN-L)
- 2314-6753
- PMC
- PMC7008274
- OpenAlex
- W3003361037
- Cited by
- 34
- References
- 43
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 5 · 2023: 2 · 2022: 15 · 2021: 3 · 2020: 3
- FWCI
- 4.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Journal of Diabetes Research (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Eritrean Ministry of Health
- Asmara College of Health Sciences
- Eritrea Higher Education Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, glycemic control, HbA1c, dyslipidemia, lipid profile, risk factors, waist-to-hip ratio, hypertension, estimated glomerular filtration rate, triglycerides, HDL cholesterol, LDL cholesterol, total cholesterol, sub-Saharan Africa, Eritrea, Asmara, outpatients, anthropometric parameters, sex
- MeSH terms
- Tobacco Smoking, Glycemic Control, Adult, Aged, Alcohol Drinking, Blood Glucose, Cholesterol, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Female, Glomerular Filtration Rate, Glycated Hemoglobin, Humans, Hypertension, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Obesity, Quality of Health Care, Risk Factors, Triglycerides, Multivariate Analysis, Logistic Models, Eritrea, Waist-Hip Ratio, Dyslipidemias, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.